CYLD-mediated signaling and diseases.

Area of Science:

• Molecular Biology
• Cellular Signaling
• Cardiovascular Research

Background:

• The cylindromatosis (CYLD) gene encodes a deubiquitinating enzyme critical for cellular processes.
• CYLD regulates key signaling pathways, including Nuclear Factor kappa B (NFkB) and Mitogen-Activated Protein Kinase (MAPK).
• Dysregulation of CYLD is implicated in various diseases, including cancer and inflammatory conditions.

Purpose of the Study:

• To review the expression, function, and regulation of CYLD.
• To explore the emerging role of CYLD in cardiovascular disease pathogenesis.
• To consolidate current literature on CYLD's involvement in diverse cellular functions and disease states.

Main Methods:

• Literature review of existing studies on CYLD.
• Analysis of research linking CYLD to cellular signaling cascades.
• Examination of evidence connecting CYLD to various pathological conditions, with a focus on cardiovascular dysfunction.

Main Results:

• CYLD acts as a crucial regulator of immune responses, inflammation, cell death, and proliferation.
• CYLD's catalytic activity influences key signaling intermediates in NFkB and MAPK pathways.
• Emerging evidence suggests a significant role for CYLD in cardiovascular dysfunction.

Conclusions:

• CYLD is a versatile regulator of cellular processes and signaling pathways.
• CYLD's activity is modulated by phosphorylation and other regulatory factors.
• Further research into CYLD's role in cardiovascular disease is warranted.